Report cover image

Multiple Myeloma Drugs Global Market Report 2023 Including: 1) By Drug Type: Immunomodulatory Drugs; Proteasome Inhibitors; Histone Deacetylase Inhibitors; Monoclonal Antibody Drugs; Steroids 2) By Therapy: Targeted Therapy; Biologic Therapy; Chemotherapy

Publisher The Business Research Company
Published Sep 21, 2023
Length 175 Pages
SKU # BRC18193073

Description

Multiple Myeloma Drugs Global Market Report 2023

Including: 1) By Drug Type: Immunomodulatory Drugs; Proteasome Inhibitors; Histone Deacetylase Inhibitors; Monoclonal Antibody Drugs; Steroids2) By Therapy: Targeted Therapy; Biologic Therapy; Chemotherapy3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies4) By End-User: Men; WomenCovering: Pfizer Inc.; Johnson & Johnson Pvt. Ltd; Merck & Co. Inc.; AbbVie Inc.; Bayer AG.


Multiple Myeloma Drugs Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiple myeloma drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for multiple myeloma drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The multiple myeloma drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Drug Type: Immunomodulatory Drugs; Proteasome Inhibitors; Histone Deacetylase Inhibitors; Monoclonal Antibody Drugs; Steroids; Other Drug Types

2) By Therapy: Targeted Therapy; Biologic Therapy; Chemotherapy; Other Therapies

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

4) By End-User: Men; Women

Companies Mentioned: Pfizer Inc.; Johnson & Johnson Pvt. Ltd; Merck & Co. Inc.; AbbVie Inc.; Bayer AG.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Multiple Myeloma Drugs Market Characteristics
3. Multiple Myeloma Drugs Market Trends And Strategies
4. Multiple Myeloma Drugs Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Multiple Myeloma Drugs Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Multiple Myeloma Drugs Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Multiple Myeloma Drugs Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Multiple Myeloma Drugs Market Segmentation
6.1. Global Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Immunomodulatory Drugs
Proteasome Inhibitors
Histone Deacetylase Inhibitors
Monoclonal Antibody Drugs
Steroids
Other Drug Types
6.2. Global Multiple Myeloma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Targeted Therapy
Biologic Therapy
Chemotherapy
Other Therapies
6.3. Global Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.4. Global Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Men
Women
7. Multiple Myeloma Drugs Market Regional And Country Analysis
7.1. Global Multiple Myeloma Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Multiple Myeloma Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Multiple Myeloma Drugs Market
8.1. Asia-Pacific Multiple Myeloma Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Multiple Myeloma Drugs Market
9.1. China Multiple Myeloma Drugs Market Overview
9.2. China Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Multiple Myeloma Drugs Market
10.1. India Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Multiple Myeloma Drugs Market
11.1. Japan Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Multiple Myeloma Drugs Market
12.1. Australia Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Multiple Myeloma Drugs Market
13.1. Indonesia Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Multiple Myeloma Drugs Market
14.1. South Korea Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Multiple Myeloma Drugs Market
15.1. Western Europe Multiple Myeloma Drugs Market Overview
15.2. Western Europe Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Multiple Myeloma Drugs Market
16.1. UK Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Multiple Myeloma Drugs Market
17.1. Germany Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Multiple Myeloma Drugs Market
18.1. France Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Multiple Myeloma Drugs Market
19.1. Italy Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Multiple Myeloma Drugs Market
20.1. Spain Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Multiple Myeloma Drugs Market
21.1. Eastern Europe Multiple Myeloma Drugs Market Overview
21.2. Eastern Europe Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Multiple Myeloma Drugs Market
22.1. Russia Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Multiple Myeloma Drugs Market
23.1. North America Multiple Myeloma Drugs Market Overview
23.2. North America Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Multiple Myeloma Drugs Market
24.1. USA Multiple Myeloma Drugs Market Overview
24.2. USA Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Multiple Myeloma Drugs Market
25.1. Canada Multiple Myeloma Drugs Market Overview
25.2. Canada Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Multiple Myeloma Drugs Market
26.1. South America Multiple Myeloma Drugs Market Overview
26.2. South America Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Multiple Myeloma Drugs Market
27.1. Brazil Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Multiple Myeloma Drugs Market
28.1. Middle East Multiple Myeloma Drugs Market Overview
28.2. Middle East Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Multiple Myeloma Drugs Market
29.1. Africa Multiple Myeloma Drugs Market Overview
29.2. Africa Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Multiple Myeloma Drugs Market Competitive Landscape And Company Profiles
30.1. Multiple Myeloma Drugs Market Competitive Landscape
30.2. Multiple Myeloma Drugs Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson Pvt. Ltd
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Merck & Co. Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. AbbVie Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Bayer AG.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Multiple Myeloma Drugs Market Other Major And Innovative Companies
31.1. Roche Holding AG
31.2. Novartis AG
31.3. Sanofi S.A.
31.4. Bristol-Myers Squibb Company
31.5. GlaxoSmithKline Plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Eli Lilly and Company
31.8. Kite Pharma Inc
31.9. Amgen Inc.
31.10. AstraZeneca plc
31.11. Teva Pharmaceutical Industries Ltd.
31.12. Regeneron Pharmaceuticals Inc.
31.13. Daiichi Sankyo Company
31.14. Daiichi Sankyo Co. Ltd.
31.15. Lonza Group AG
32. Global Multiple Myeloma Drugs Market Competitive Benchmarking
33. Global Multiple Myeloma Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Multiple Myeloma Drugs Market
35. Multiple Myeloma Drugs Market Future Outlook and Potential Analysis
35.1 Multiple Myeloma Drugs Market In 2027 - Countries Offering Most New Opportunities
35.2 Multiple Myeloma Drugs Market In 2027 - Segments Offering Most New Opportunities
35.3 Multiple Myeloma Drugs Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us